Development of a drug delivery device: Using the femtosecond laser to modify cochlear implant electrodes

Cochlear Implants International

Volumn 8, Issue 1, 2007, Pages 38-52

  Stöver, Timo ^a   Paasche, G ^a   Lenarz, T ^a   Ripken, T ^b   Breitenfeld, P ^b   Lubatschowski, H ^b   Fabian, T ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LASER ZENTRUM HANNOVER E V   (Germany)

^c LEIBNIZ UNIVERSITY HANNOVER   (Germany)

Author keywords

Electrode modification; Inner ear drug delivery; Silicone processing

Indexed keywords

SILICONE;

ARTICLE; COCHLEA PROSTHESIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELECTRODE; FEMTOSECOND LASER; IMPLANTATION; IN VITRO STUDY; INNER EAR; LASER;

COCHLEA; COCHLEAR IMPLANTS; DRUG DELIVERY SYSTEMS; ELECTRODES, IMPLANTED; FEASIBILITY STUDIES; HUMANS; LASERS;

EID: 34147113925     PISSN: 14670100     EISSN: None     Source Type: Journal    
DOI: 10.1002/cii.329     Document Type: Article

References (23)

1. Brown JN, Miller JM, Altschuler RA, Nuttall AL (1993) Osmotic pump implant for chronic infusion of drugs into the inner ear. Hearing Research 70: 167-172.
2. Dazert S, Kim D, Luo L, Aletsee C, Garfunkel S, Maciag T, Baird A, Ryan AF (1998) Focal delivery of fibroblast growth factor-1 by transfected cells induces spiral ganglion neurite targeting in vitro. Journal of Cellular Physiology 177: 123-129.
3. Dillier N, Battmer R-D, Döring WH, Müller-Deile J (1995) Multicentric field evaluation of a new speech coding strategy for cochlear implants. Audiology 34: 145-159.
4. Gillespie LN, Clark GM, Bartlett PF, Marzella PL (2001) LIF is more potent than BDNF in promoting neurite outgrowth of mammalian auditory neurons in vitro. NeuroReport 12: 275-279.
5. Hakuba N, Watabe K, Hyodo J, Ohashi T, Eto Y, Taniguchi M, Yang L, Tanaka J, Hata R (2003) Adenovirus-mediated overexpression of a gene prevents hearing loss and progressive inner hair cell loss after transient cochlear ischemia in gerbils. Gene Therapy 10: 426-433.
6. Incesulu A, Nadol JB, Jr (1998) Correlation of acoustic threshold measures and spiral ganglion cell survival in severe to profound sensorineural hearing loss: implications for cochlear implantation. Annals of Otology, Rhinology and Laryngology 107: 906-911.
7. Lenarz T, Battmer RD, Goldring JE, Neuburger J, Kuzma J, Reuter G (2000) New electrode concepts (Modiolus-hugging electrodes). In Kim CS, Chang SO, Lim D (eds) Updates in cochlear implantation. Adv Otorhinolaryngol Basel: Karger, 57: 347-353.
8. Loesel FH, Brockhaus P, Fischer JP, Götz MH, Noack F, Bille JF (1994) Comparison of tissue ablation by ultrashort laser pulses in the nano-, pico- and femtosecond range. International Society for Optical Engineering 2323: 227-233.
9. Malgrange B, Lefebvre PP, Martin D, Staecker H, Van de Water TR, Moonen G (1996) NT-3 has a tropic effect on process outgrowth by postnatal auditory neurones in vitro. NeuroReport 7: 2495-2499.
10. Miller JM, Chi DH, O'Keeffe LJ, Kruszka P, Raphael Y, Altschuler RA (1997) Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. International Journal of Developmental Neuroscience 15: 631-643.
11. Momma C, Chichkov BN, Nolte S, Von Alvensleben F, Tünnermann A, Welling H, Wellegehausen B (1996) Short-pulse laser ablation of solid targets. Optics Communications 129: 134-142.
12. Momma C, Nolte S, Chichkov BN, Von Alvensleben F, Tünnermann A (1997) Precise laser ablation with ultrashort pulses. Applied Surface Science 109/110: 15-19.
13. Neev J, Da Silva LB, Feit MD, Perry MD, Rubenchik AM, Stuart BC (1996) Ultrashort pulse lasers for hard tissue ablation. IEEE Journal of Selected Topics in Quantum Electronics 2: 790-799.
14. Paasche G, Gibson P, Averbeck T, Becker H, Lenarz T, Stöver T (2003) Technical report: modification of a cochlear implant electrode for drug delivery to the inner ear. Otology and Neurotology 24:222-227.
15. Pirvola U, Ylikoski J, Palgi J, Lehtonen E, Arumäe U, Saarma M (1992) Brain-derived neurotrophic factor and neurotrophin 3 mRNAs in the peripheral target fields of developing inner ear ganglia. Proceedings of the National Academy of Science 89: 9915-9919.
16. Prieskorn DM, Miller JM (2000) Technical report: chronic and acute intracochlear infusion in rodents. Hearing Research 140: 212-215.
17. Shoji F, Miller AL, Mitchell A, Yamasoba T, Altschuler RA, Miller JM (2000) Differential protective effects of neurotrophins in the attenuation of noise-induced hair cell loss. Hearing Research 146: 134-142.
18. Suzuki M, Yagi M, Brown JN, Miller AL, Miller JM, Raphael Y (2000) Effect of transgenic GDNF expression on gentamicin-induced cochlear and vestibular toxicity. Gene Therapy 7: 1046-1054.
19. Tykocinski M, Cohen LT, Pyman BC, Roland T, Jr, Treaba C, Palamara J, Dahm MC, Shepherd RK, Xu J, Cowan RS, Cohen NL, Clark GM (2000) Comparison of electrode position in the human cochlea using various perimodiolar electrode arrays. American Journal of Otology 21: 205-211.
20. Tykocinski M, Saunders E, Cohen LT, Treaba C, Briggs RJS, Gibson P, Clark GM, Cowan RS (2001) The Contour electrode array: safety study and initial patient trials of a new perimodiolar design. Otology and Neurotology 22: 33-41.
21. Vandali AE (2001) Emphasis of short-duration acoustic speech cues for cochlear implant users. Journal of the Acoustical Society of America 109: 2049-2061.
22. Yagi M, Magal E, Sheng Z, Ang KA, Raphael Y (1999) Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell line-derived neurotrophic factor. Human Gene Therapy 10: 813-823.
23. Yagi M, Kanzaki S, Kawamoto K, Shin B, Shah PP, Magal E, Sheng J, Raphael Y (2000) Spiral ganglion neurons are protected from degeneration by GDNF gene therapie. Journal of the Association for Research in Otology 01: 315-325.